Literature DB >> 5646939

The status of topical antibacterial therapy in the treatment of burns.

J A Moncrief.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 5646939

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  10 in total

1.  In vitro penetration of topical antiseptics through eschar of burn patients.

Authors:  M M Stefanides; C E Copeland; S D Kominos; R B Yee
Journal:  Ann Surg       Date:  1976-04       Impact factor: 12.969

Review 2.  Prognosis and treatment of burns.

Authors:  R Mann; D Heimbach
Journal:  West J Med       Date:  1996-10

3.  The contribution of a bacterially isolated environment to the prevention of infection in seriously burned patients.

Authors:  J F Burke; W C Quinby; C C Bondoc; E M Sheehy; H C Moreno
Journal:  Ann Surg       Date:  1977-09       Impact factor: 12.969

4.  Macrophage dysfunction after burn injury.

Authors:  L D Loose; J Turinsky
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

5.  Sulfamylon therapy in severe burns: two hundred forty-six cases compared to previous experience.

Authors:  B W Haynes; W E Gayle; G E Madge
Journal:  Ann Surg       Date:  1969-10       Impact factor: 12.969

6.  Effect of current therapy on burn mortality.

Authors:  P Silverstein; D P Dressler
Journal:  Ann Surg       Date:  1970-01       Impact factor: 12.969

7.  The effect of topical sulfamylon on the insensible weight loss of burned patients.

Authors:  B E Zawacki; F C Divincenti; J A Moncrief
Journal:  Ann Surg       Date:  1969-02       Impact factor: 12.969

8.  Biochemical and functional alterations in macrophages after thermal injury.

Authors:  L D Loose; R Megirian; J Turinsky
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

Review 9.  Mafenide acetate cream: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

10.  Correlation between pseudomonas burn wound infection and granulocyte antibacterial activity.

Authors:  D D McEuen; P Blair; V E Delbene; K Eurenius
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.